# Daily ticker review — 2026-10-27

## Brief and selection rule

Expand the existing 22-symbol US-exchange-listed paper-trading universe to 30. Keep the existing entry strategy unchanged; evaluate new names as swing-trade candidates. New additions were screened for US exchange listing, positive trailing P/E below 15 at the data snapshot, adequate liquidity/market capitalization, recent earnings/cash-flow evidence, and diversification. P/E is a screening filter, not a buy signal; Wyckoff confirmation and a valid live bid/ask are still required before any paper order.

Valuation snapshot: Yahoo Finance yfinance.Ticker.info, retrieved 2026-10-27 in the Jerusalem morning, before the US regular session. Trailing/forward P/E and FCF are vendor-reported and may be stale, restated, or distorted by one-off earnings, especially for insurers and cyclical producers. Figures are USD; FCF is trailing vendor data. Recent operating evidence is sourced from issuer releases linked below. This is a watchlist review, not investment advice or a trade instruction.

## Selected eight additions (ranked)

| Rank | Ticker / sector | TTM P/E / forward P/E | Recent evidence and why it made the cut | Main risk / watch item | Official source |
|---|---|---:|---|---|---|
| 1 | CI — healthcare services | 12.6 / 9.1 | Q2 2026 adjusted operating income was $2.1B ($7.78/share), up from $1.9B ($7.20); company raised FY26 adjusted EPS outlook to at least $30.45. FCF about $8.0B. | Medical-cost trend, Medicare/ACA policy and PBM regulation; monitor medical care ratio and guidance. | [Q2 2026 release](https://newsroom.thecignagroup.com/2026-07-30-The-Cigna-Group-Reports-Strong-Second-Quarter-2026-Results,-Raises-2026-Outlook) |
| 2 | TRV — property/casualty insurance | 10.5 / 12.9 | Q3 2026 net income $1.917B, core income $1.947B; reported ROE 24.7%, core ROE 22.1%. | Catastrophe and reserve volatility; strong quarter can be unusually favorable. | [Q3 2026 release](https://investor.travelers.com/newsroom/press-releases/news-details/2026/Travelers-Reports-Excellent-Third-Quarter-and-Year-to-Date-Results/default.aspx) |
| 3 | BMY — pharmaceuticals | 13.6 / 9.3 | TTM FCF about $8.1B and operating margin about 34% in vendor snapshot; inexpensive relative to forward earnings. Q3 2026 results were scheduled for Oct. 29, making this a near-term catalyst/watch item. | Product concentration and patent expiries; net debt around $34B (vendor total debt less cash); binary clinical/regulatory news. | [Q2 2026 results](https://news.bms.com/news/corporate-financial/2026/Bristol-Myers-Squibb-Reports-Second-Quarter-Financial-Results-for-2026/default.aspx); [Q3 results event](https://investors.bms.com/iframes/events-and-presentations/event-details/2026/Bristol-Myers-Squibb-Q3-2026-Results-Conference-Call/default.aspx) |
| 4 | TROW — asset management | 10.4 / 10.1 | TTM FCF about $2.0B; vendor snapshot showed net cash (cash ~$3.23B vs debt ~$0.45B). | September 2026 AUM was $1.86T, but net outflows were $12.2B; fee pressure and persistent outflows could erode earnings. | [Q2 2026 results](https://investors.troweprice.com/news-releases/news-release-details/t-rowe-price-group-reports-second-quarter-2026-results); [September AUM/outflows](https://investors.troweprice.com/news-releases/news-release-details/t-rowe-price-group-reports-month-end-assets-under-management-6) |
| 5 | HPQ — computer hardware | 13.0 / 10.8 | Fiscal Q3 2026 revenue $15.7B, up 12.5% year over year; TTM FCF about $3.4B. | Mature PC/printing franchises, thin operating margin (~5.4%), component costs and replacement-cycle volatility. | [Fiscal Q3 2026 results](https://www.hp.com/us-en/newsroom/press-releases/2026/hp-inc-reports-fiscal-2026-third-quarter-results.html) |
| 6 | CF — nitrogen fertilizer | 9.0 / 10.6 | First-half 2026 net earnings $1.34B and adjusted EBITDA $2.18B; production reached 98% of available ammonia capacity. | Highly cyclical fertilizer pricing and natural-gas input costs; earnings can fall sharply through the cycle. | [First-half/Q2 2026 results](https://ir.cfindustries.com/Investors/news/news-details/2026/CF-Industries-Holdings-Inc--Reports-First-Half-2026-Net-Earnings-of-1-34-Billion-Adjusted-EBITDA-of-2-18-Billion/default.aspx) |
| 7 | PHM — homebuilding | 12.9 / 12.7 | Q2 2026 net income $472M ($2.48/share); vendor snapshot FCF about $0.84B and operating margin about 16%. Adds a second builder for relative screening. | Mortgage affordability, cancellations/incentives and housing-cycle risk; correlated with existing DHI. Review DHI vs PHM concentration in later passes. | [Q2 2026 results](https://pultegroupinc.com/investor-relations/news/news-details/2026/PulteGroup-Reports-Second-Quarter-2026-Financial-Results/default.aspx) |
| 8 | AIZ — specialty insurance/protection | 13.7 / 12.2 | Q2 2026 company release reported record results and raised its full-year outlook; vendor snapshot FCF ~$2.15B and ROE ~18%. | Partner/product concentration (mobile-device protection and global housing), catastrophe losses and volatile investment/insurance results. | [Q2 2026 results](https://www.assurant.com/news-insights/news_releases/assurant-second-quarter-2026-financial-results) |

The first six have more diversified exposures; PHM overlaps with existing DHI, while TRV/AIZ overlap broadly in insurance. Keep total sector exposure under review rather than treating low P/E as sufficient.

## Re-screen of original 22

Yahoo's 2026-10-27 snapshot flagged GM (TTM P/E ~16.7), XOM (~23.8), CVX (~22.3), and MO (~15.5) above the original <15 trailing-P/E screen. F, INTC, and KHC had no positive trailing P/E available (forward P/E alone is not a substitute). They remain in the current list for now because there are existing paper positions; this review does not liquidate or cancel anything. The daily review should re-check fundamentals and live positions, label held names as position-locked, and never submit orders. Remove an unheld name only after documenting the reason and a replacement; never exceed 30.

## Implemented list treatment

Current universe is exactly 30: original 22 plus the eight above. All eight new names are added to SWING_TRADE_STOCKS with the pre-existing $30,000 per-symbol notional. No strategy thresholds, position sizes, current holdings, or orders were changed by this research edit. The $30,000 bucket is the code's existing setting; this task did not change the separate day-vs-long-term allocation policy.

## Daily review checklist

1. Load the canonical WATCHLIST from src/trade_cycle.py; verify US exchange listing, TTM P/E, current earnings/FCF, liquidity, sector mix, and recent issuer news using primary sources.
2. Compare every name, not only new ideas. Report data failures and stale metrics instead of guessing.
3. Check live IBKR paper positions/open orders read-only before recommending removals; retain held names as position-locked or explicitly track them outside the entry list, and never liquidate/cancel.
4. Rank replacements against valuation, financial quality, catalyst, quote/liquidity quality, and sector concentration. Keep WATCHLIST at or below 30; make no change if evidence is insufficient.
5. If changing files, update WATCHLIST and exactly one trade bucket per ticker, validate uniqueness/count/bucket coverage and Python syntax, and save a dated review note. Do not place, modify, or cancel orders; do not change notional sizing; report the diff and rationale.
